SCPHARMACEUTICALS INC. Diluted Shares Outstanding (Weighted Average)
SCPHARMACEUTICALS INC. reported Diluted Shares Outstanding (Weighted Average) of 53.72 million shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-08-07
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 53.72M shares, a 37.80% increase year-over-year.
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 53.68M shares, a 37.80% increase year-over-year.
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 53.53M shares, a 37.99% increase year-over-year.
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 46.56M shares, a 20.12% increase year-over-year.
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 44.52M shares, a 15.59% increase from fiscal 2023.
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 38.51M shares, a 35.81% increase from fiscal 2022.
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 28.36M shares, a 3.68% increase from fiscal 2021.
- SCPHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 27.35M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2025-06-30 | 53.72M shares 10-Q · filed 2025-08-07 | 53.70M shares 10-Q · filed 2025-08-07 | 53.64M shares derived: average of 3 quarters · filed 2025-08-07 | 51.87M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 53.68M shares 10-Q · filed 2025-05-14 | 53.60M shares derived: average of 2 quarters · filed 2025-05-14 | 51.25M shares derived: average of 3 quarters · filed 2025-05-14 | 48.19M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-12-31 | 53.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 50.04M shares derived: average of 2 quarters · filed 2025-03-19 | 46.36M shares derived: average of 3 quarters · filed 2025-08-07 | 44.52M shares 10-K · filed 2025-03-19 |
| 2024-09-30 | 46.56M shares 10-Q · filed 2024-11-13 | 42.77M shares derived: average of 2 quarters · filed 2025-08-07 | 41.52M shares 10-Q · filed 2024-11-13 | 40.82M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | 38.98M shares 10-Q · filed 2025-08-07 | 38.97M shares 10-Q · filed 2025-08-07 | 38.91M shares derived: average of 3 quarters · filed 2025-08-07 | 38.87M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 38.95M shares 10-Q · filed 2025-05-14 | 38.87M shares derived: average of 2 quarters · filed 2025-05-14 | 38.83M shares derived: average of 3 quarters · filed 2025-05-14 | 38.80M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 38.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 38.78M shares derived: average of 2 quarters · filed 2025-03-19 | 38.75M shares derived: average of 3 quarters · filed 2025-03-19 | 38.51M shares 10-K · filed 2025-03-19 |
| 2023-09-30 | 38.76M shares 10-Q · filed 2024-11-13 | 38.73M shares derived: average of 2 quarters · filed 2024-11-13 | 38.42M shares 10-Q · filed 2024-11-13 | 36.64M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 38.69M shares 10-Q · filed 2024-08-14 | 38.25M shares 10-Q · filed 2024-08-14 | 35.93M shares derived: average of 3 quarters · filed 2024-08-14 | 33.80M shares derived: average of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 37.80M shares 10-Q · filed 2024-05-14 | 34.54M shares derived: average of 2 quarters · filed 2024-05-14 | 32.16M shares derived: average of 3 quarters · filed 2024-05-14 | 30.97M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 31.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 29.34M shares derived: average of 2 quarters · filed 2024-03-13 | 28.69M shares derived: average of 3 quarters · filed 2024-03-13 | 28.36M shares 10-K · filed 2024-03-13 |
| 2022-09-30 | 27.40M shares 10-Q · filed 2023-11-08 | 27.39M shares derived: average of 2 quarters · filed 2023-11-08 | 27.38M shares 10-Q · filed 2023-11-08 | 27.38M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 27.38M shares 10-Q · filed 2023-08-10 | 27.37M shares 10-Q · filed 2023-08-10 | 27.37M shares derived: average of 3 quarters · filed 2023-08-10 | 27.37M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 27.37M shares 10-Q · filed 2023-05-10 | 27.36M shares derived: average of 2 quarters · filed 2023-05-10 | 27.36M shares derived: average of 3 quarters · filed 2023-05-10 | 27.36M shares derived: average of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | 27.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 27.36M shares derived: average of 2 quarters · filed 2023-03-22 | 27.36M shares derived: average of 3 quarters · filed 2023-03-22 | 27.35M shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 27.36M shares 10-Q · filed 2022-11-09 | 27.36M shares derived: average of 2 quarters · filed 2022-11-09 | 27.35M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 27.36M shares 10-Q · filed 2022-08-09 | 27.35M shares 10-Q · filed 2022-08-09 |